ESR1 and breast carcinoma: To investigate whether AMP has an anti-tumor role in breast cancer, the CCK-8 assay was adopted to evaluate the cytotoxic effects of AMP on estrogen receptor- positive and negative breast cancer cells lines MCF-7 and MDA-MB-231, as well as human normal breast epithelial cells MCF-10A, respectively.